Current location - Trademark Inquiry Complete Network - Trademark inquiry - Strategic deeds of Jinmu Pharmaceutical Group
Strategic deeds of Jinmu Pharmaceutical Group

Built the "No. 1 Borneol Factory in the North"

After understanding the market, Jinmu Group invested more than 6 million yuan to build the first borneol production in northern my country with an annual output of 200 tons of borneol. enterprise. After that, "Jinmu" brand borneol quickly occupied the domestic market in more than a dozen provinces and cities, becoming the borneol production base for more than 60 pharmaceutical companies including Tianjin Zhongxin Pharmaceutical Group. "Jinmu" borneol has been rated as a consumer trustworthy product by Hebei Province for three consecutive years.

In 2005, "Jinmu Brand" borneol began to go abroad, exported to Europe, America and Southeast Asian countries, becoming the first medicinal product export enterprise in Anguo City.

In 2006, Jinmu Pharmaceutical Co., Ltd. was awarded the title of "Pharmaceutical Pioneer" by the Anguo Municipal Party Committee and Municipal Government, and became a municipal enterprise supported by the Anguo Municipal Party Committee and Municipal Government.

Built a "Modern Traditional Chinese Medicine Pharmaceutical Factory"

In 2007, Jinmu Pharmaceutical invested 180 million yuan to build a new modern traditional Chinese medicine pharmaceutical enterprise covering an area of ??106 acres. The first phase of the project includes a traditional Chinese medicine extraction workshop, a traditional Chinese medicine preparation workshop and supporting facilities, as well as administrative, scientific research and information office buildings. In the second phase of the project, the Chinese patent medicine workshop and the new medicinal borneol plant purchased 462 sets of internationally advanced production equipment, 5 modern production lines and testing equipment for tablets, tinctures, capsules, etc., further expanding the scale of operations and further enhancing the strength of the enterprise. , Jinmu Group quickly became one of the leading enterprises in the national pharmaceutical industry.

Merged the "century-old name - Baoding Traditional Chinese Medicine Pharmaceutical Factory"

In 2008, Jinmu Group invested 60 million yuan and merged with Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd. Baoding Traditional Chinese Medicine Pharmaceutical Co., Ltd., formerly known as the Baoding branch of Tianjin Lerentang, has a history of nearly a hundred years. The major move of merging Baoding Pharmaceutical has injected new vitality into the group. Jinmu Company relies on Baoding Pharmaceutical's strict traditional Chinese medicine processing methods, time-honored ancient prescriptions, palace secret recipes and folk prescriptions, and six production lines including extraction, tablets and pills, integrating its own advanced With the latest pharmaceutical technology, we have developed products with significant curative effect such as Guanxinjing, Weihuoling, and Apocynum Antihypertensive Tablets. We have obtained 94 national drug approval numbers in seven categories, including "Weihuoling" and "Guanxinjing". "It has obtained the national patent certificate and the registration certificate of Chinese medicine name and trademark, and has won many awards in national, provincial and municipal variety competitions.

Among them, Guan Xinjing also won the International Gold Medal at the Second Canadian Traditional Chinese Medicine Products (Technology) Expo, winning a good reputation for traditional Chinese medicine in the international market. Guanxinjing, Apocynum antihypertensive tablets, and Qingnao antihypertensive tablets are exported to Canada, North America, Southeast Asia and other countries and regions, and have won the favor and trust of consumers around the world.